Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema

Antimicrob Agents Chemother. 2011 May;55(5):2478-80. doi: 10.1128/AAC.01560-10. Epub 2011 Mar 14.

Abstract

Candida empyema is a serious complication of disseminated candidiasis. However, little is known about the intrapleural pharmacokinetics of echinocandins. We report the penetration of anidulafungin into the pleural fluid of a patient with Candida tropicalis empyema. The anidulafungin ratio for the area under the concentration-time curve from 0 h to the last measurement between pleural fluid and serum values was only 0.125 (12.5%), with pleural fluid concentrations ranging between 0.67 and 0.88 μg/ml.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Anidulafungin
  • Antifungal Agents / pharmacokinetics*
  • Antifungal Agents / therapeutic use*
  • Candida / drug effects*
  • Candida / pathogenicity*
  • Echinocandins / pharmacokinetics*
  • Echinocandins / therapeutic use*
  • Empyema / drug therapy*
  • Empyema / microbiology*
  • Empyema, Pleural / drug therapy
  • Empyema, Pleural / microbiology
  • Humans
  • Male

Substances

  • Antifungal Agents
  • Echinocandins
  • Anidulafungin